Long Noncoding RNAs as Biomarkers in Cancer

Disease Markers

Volumn 2017, Issue , 2017, Pages

  Bolha, Luka ^a   Ravnik Glavač, Metka ^a   Glavač, Damjan ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; CELL FREE NUCLEIC ACID; TUMOR MARKER;

BODY FLUID; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER THERAPY; EPIGENETICS; HUMAN; MALIGNANT NEOPLASM; PROTEIN EXPRESSION; REVIEW; BLOOD; GENETIC EPIGENESIS; GENETICS; NEOPLASM;

BIOMARKERS, TUMOR; CELL-FREE NUCLEIC ACIDS; EPIGENESIS, GENETIC; HUMANS; NEOPLASMS; RNA, LONG NONCODING;

EID: 85021630443     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2017/7243968     Document Type: Review

References (222)

1. J. S. Mattick, "Non-coding RNAs: the architects of eukaryotic complexity, " EMBO Reports, vol. 2, no. 11, pp. 986-991, 2001.
2. C. Lee and N. Kikyo, "Strategies to identify long noncoding RNAs involved in gene regulation, " Cell & Bioscience, vol. 2, no. 1, p. 37, 2012.
3. J. J. Quinn and H. Y. Chang, "Unique features of long noncoding RNA biogenesis and function, " Nature Reviews. Genetics, vol. 17, no. 1, pp. 47-62, 2016.
4. J. Harrow, A. Frankish, J. M. Gonzalez et al., "GENCODE: the reference human genome annotation for the ENCODE project, " Genome Research, vol. 22, no. 9, pp. 1760-1774, 2012.
5. T. Alam, Y. A. Medvedeva, H. Jia, J. B. Brown, L. Lipovich, and V. B. Bajic, "Promoter analysis reveals globally differential regulation of human long non-coding RNA and protein-coding genes, " PloS One, vol. 9, no. 10, article e109443, 2014.
6. O. Wapinski and H. Y. Chang, "Long noncoding RNAs and human disease, " Trends in Cell Biology, vol. 21, no. 6, pp. 354-361, 2011.
7. C. A. Brosnan and O. Voinnet, "The long and the short of noncoding RNAs, " Current Opinion in Cell Biology, vol. 21, no. 3, pp. 416-425, 2009.
8. C. I. Brannan, E. C. Dees, R. S. Ingram, and S. M. Tilghman, "The product of the H19 gene may function as an RNA, " Molecular and Cellular Biology, vol. 10, no. 1, pp. 28-36, 1990.
9. N. Brockdorff, A. Ashworth, G. F. Kay et al., "The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus, " Cell, vol. 71, no. 3, pp. 515-526, 1992.
10. H. van Bakel and T. R. Hughes, "Establishing legitimacy and function in the new transcriptome, " Briefings in Functional Genomics & Proteomics, vol. 8, no. 6, pp. 424-436, 2009.
11. Y. Okazaki, M. Furuno, T. Kasukawa et al., "Analysis of the mouse transcriptome based on functional annotation of 60, 770 full-length cDNAs, " Nature, vol. 420, no. 6915, pp. 563-573, 2002.
12. J. L. Rinn and H. Y. Chang, "Genome regulation by long noncoding RNAs, " Annual Review of Biochemistry, vol. 81, pp. 145-166, 2012.
13. W. Hu, J. R. Alvarez-Dominguez, and H. F. Lodish, "Regulation of mammalian cell differentiation by long non-coding RNAs, " EMBO Reports, vol. 13, no. 11, pp. 971-983, 2012.
14. R. A. Flynn and H. Y. Chang, "Long noncoding RNAs in cellfate programming and reprogramming, " Cell Stem Cell, vol. 14, no. 6, pp. 752-761, 2014.
15. M. N. Rossi and F. Antonangeli, "LncRNAs: new players in apoptosis control, " International Journal of Cell Biology, vol. 2014, Article ID 473857, 7 pages, 2014.
16. L. W. Harries, "Long non-coding RNAs and human disease, " Biochemical Society Transactions, vol. 40, no. 4, pp. 902-906, 2012.
17. K. Qian, G. Liu, Z. Tang et al., "The long non-coding RNA NEAT1 interacted with MIR-101 modulates breast cancer growth by targeting EZH2, " Archives of Biochemistry and Biophysics, vol. 615, pp. 1-9, 2017.
18. B. Liu, C. F. Pan, Z. C. He et al., "Long noncoding RNALET suppresses tumor growth and EMT in lung adenocarcinoma, " BioMed Research International, vol. 2016, Article ID 4693471, 9 pages, 2016.
19. K. Zhang, H. Shi, H. Xi et al., "Genome-wide lncRNA microarray profiling identifies novel circulating lncRNAs for detection of gastric cancer, " Theranostics, vol. 7, no. 1, pp. 213-227, 2017.
20. Z. Y. Yang, F. Yang, Y. L. Zhang et al., "LncRNA-ANCR down-regulation suppresses invasion and migration of colorectal cancer cells by regulating EZH2 expression, " Cancer Biomarkers: Section A of Disease Markers, vol. 18, no. 1, pp. 95-104, 2017.
21. P. Kapranov, J. Cheng, S. Dike et al., "RNA maps reveal new RNA classes and a possible function for pervasive transcription, " Science (New York, N. Y.), vol. 316, no. 5830, pp. 1484-1488, 2007.
22. R. Spizzo, M. I. Almeida, A. Colombatti, and G. A. Calin, "Long non-coding RNAs and cancer: a new frontier of translational researcH∞" Oncogene, vol. 31, no. 43, pp. 4577-4587, 2012.
23. J. E. Wilusz, H. Sunwoo, and D. L. Spector, "Long noncoding RNAs: functional surprises from the RNA world, " Genes & Development, vol. 23, no. 13, pp. 1494-1504, 2009.
24. R. Flippot, G. G. Malouf, X. Su, R. Mouawad, J. P. Spano, and D. Khayat, "Cancer subtypes classification using long non-coding RNA, " Oncotarget, vol. 7, no. 33, pp. 54082-54093, 2016.
25. T. Derrien, R. Johnson, G. Bussotti et al., "The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression, " Genome Research, vol. 22, no. 9, pp. 1775-1789, 2012.
26. C. P. Ponting, P. L. Oliver, and W. Reik, "Evolution and functions of long noncoding RNAs, " Cell, vol. 136, no. 4, pp. 629-641, 2009.
27. M. Guttman and J. L. Rinn, "Modular regulatory principles of large non-coding RNAs, " Nature, vol. 482, no. 7385, pp. 339-346, 2012.
28. T. R. Mercer, M. E. Dinger, and J. S. Mattick, "Long noncoding RNAs: insights into functions, " Nature Reviews. Genetics, vol. 10, no. 3, pp. 155-159, 2009.
29. G. St Laurent, C. Wahlestedt, and P. Kapranov, "The landscape of long non-coding RNA classification, " Trends in Genetics: TIG, vol. 31, no. 5, pp. 239-251, 2015.
30. Q. Wang, S. Gao, H. Li, M. Lv, and C. Lu, "Long noncoding RNAs (lncRNAs) in triple negative breast cancer, " Journal of Cellular Physiology, vol. 9999, pp. 1-8, 2017.
31. N. Bartonicek, J. L. V. Maag, and M. E. Dinger, "Long noncoding RNAs in cancer: mechanisms of action and technological advancements, " Molecular Cancer, vol. 15, no. 1, p. 43, 2016.
32. Y. Zhang, T. Shields, T. Crenshaw, Y. Hao, T. Moulton, and B. Tycko, "Imprinting of human H19: allele-specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching, " American Journal of Human Genetics, vol. 53, no. 1, pp. 113-124, 1993.
33. J. H. Luo, B. Ren, S. Keryanov et al., "Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas, " Hepatology (Baltimore, Md.), vol. 44, no. 4, pp. 1012-1024, 2006.
34. J. B. de Kok, G. W. Verhaegh, R. W. Roelofs et al., "DD3(PCA3), a very sensitive and specific marker to detect prostate tumors, " Cancer Research, vol. 62, no. 9, pp. 2695-2698, 2002.
35. T. Shi, G. Gao, and Y. Cao, "Long noncoding RNAs as novel biomarkers have a promising future in cancer diagnostics, " Disease Markers, vol. 2016, Article ID 9085195, 10 pages, 2016.
36. H. Zhang, Z. Chen, X. Wang, Z. Huang, Z. He, and Y. Chen, "Long non-coding RNA: a new player in cancer, " Journal of Hematology & Oncology, vol. 6, no. 1, p. 37, 2013.
37. M. T. Qiu, J. W. Hu, R. Yin, and L. Xu, "Long noncoding RNA: an emerging paradigm of cancer research, " Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 34, no. 2, pp. 613-620, 2013.
38. S. Xu, S. Sui, J. Zhang et al., "Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer, " International Journal of Clinical and Experimental Pathology, vol. 8, no. 5, pp. 4881-4891, 2015.
39. Q. Ji, X. Liu, X. Fu et al., "Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/beta-catenin signal pathway, " PloS One, vol. 8, no. 11, article e78700, 2013.
40. M. K. Iyer, Y. S. Niknafs, R. Malik et al., "The landscape of long noncoding RNAs in the human transcriptome, " Nature Genetics, vol. 47, no. 3, pp. 199-208, 2015.
41. X. Yan, Z. Hu, Y. Feng et al., "Comprehensive genomic characterization of long non-coding RNAs across human cancers, " Cancer Cell, vol. 28, no. 4, pp. 529-540, 2015.
42. M. B. Clark, T. R. Mercer, G. Bussotti et al., "Quantitative gene profiling of long noncoding RNAs with targeted RNA sequencing, " Nature Methods, vol. 12, no. 4, pp. 339-342, 2015.
43. S. W. Cheetham, F. Gruhl, J. S. Mattick, and M. E. Dinger, "Long noncoding RNAs and the genetics of cancer, " British Journal of Cancer, vol. 108, no. 12, pp. 2419-2425, 2013.
44. E. A. Gibb, C. J. Brown, and W. L. Lam, "The functional role of long non-coding RNA in human carcinomas, " Molecular Cancer, vol. 10, no. 1, p. 38, 2011.
45. N. Hauptman and D. Glavac, "Long non-coding RNA in cancer, " International Journal of Molecular Sciences, vol. 14, no. 3, pp. 4655-4669, 2013.
46. S. A. Mitra, A. P. Mitra, and T. J. Triche, "A central role for long non-coding RNA in cancer, " Frontiers in Genetics, vol. 3, no. 17, p. 70, 2012.
47. G. A. Calin, C. G. Liu, M. Ferracin et al., "Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas, " Cancer Cell, vol. 12, no. 3, pp. 215-229, 2007.
48. Y. F. Gao, Z. B. Wang, T. Zhu et al., "A critical overview of long non-coding RNA in glioma etiology 2016: an update, " Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 37, no. 11, pp. 14403-14413, 2016.
49. A. Fatica and I. Bozzoni, "Long non-coding RNAs: new players in cell differentiation and development, " Nature Reviews. Genetics, vol. 15, no. 1, pp. 7-21, 2014.
50. F. Lai and R. Shiekhattar, "Where long noncoding RNAs meet DNA methylation, " Cell Research, vol. 24, no. 3, pp. 263-264, 2014.
51. C. Martin and Y. Zhang, "Mechanisms of epigenetic inheritance, " Current Opinion in Cell Biology, vol. 19, no. 3, pp. 266-272, 2007.
52. R. A. Gupta, N. Shah, K. C. Wang et al., "Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis, " Nature, vol. 464, no. 7291, pp. 1071-1076, 2010.
53. L. Lu, G. Zhu, C. Zhang et al., "Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer, " Breast Cancer Research and Treatment, vol. 136, no. 3, pp. 875-883, 2012.
54. K. P. Sorensen, M. Thomassen, Q. Tan et al., "Long noncoding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer, " Breast Cancer Research and Treatment, vol. 142, no. 3, pp. 529-536, 2013.
55. F. C. Beckedorff, M. S. Amaral, C. Deocesano-Pereira, and S. Verjovski-Almeida, "Long non-coding RNAs and their implications in cancer epigenetics, " Bioscience Reports, vol. 33, no. 4, article e00061, 2013.
56. J. L. Rinn, M. Kertesz, J. K. Wang et al., "Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs, " Cell, vol. 129, no. 7, pp. 1311-1323, 2007.
57. C. Kanduri, J. Whitehead, and F. Mohammad, "The long and the short of it: RNA-directed chromatin asymmetry in mammalian X-chromosome inactivation, " FEBS Letters, vol. 583, no. 5, pp. 857-864, 2009.
58. J. Cao, "The functional role of long non-coding RNAs and epigenetics, " Biological Procedures Online, vol. 16, no. 1, p. 11, 2014.
59. Y. He, X. M. Meng, C. Huang et al., "Long noncoding RNAs: novel insights into hepatocelluar carcinoma, " Cancer Letters, vol. 344, no. 1, pp. 20-27, 2014.
60. F. Mohammad, T. Mondal, N. Guseva, G. K. Pandey, and C. Kanduri, "Kcnq1ot1 noncoding RNA mediates transcriptional gene silencing by interacting with Dnmt1, " Development (Cambridge, England), vol. 137, no. 15, pp. 2493-2499, 2010.
61. Q. Li, Z. Su, X. Xu et al., "AS1DHRS4, a head-to-head natural antisense transcript, silences the DHRS4 gene cluster in cis and trans, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 35, pp. 14110-14115, 2012.
62. C. R. Merry, M. E. Forrest, J. N. Sabers et al., "DNMT1-associated long non-coding RNAs regulate global gene expression and DNA methylation in colon cancer, " Human Molecular Genetics, vol. 24, no. 21, pp. 6240-6253, 2015.
63. R. S. Lee and C. W. Roberts, "Linking the SWI/SNF complex to prostate cancer, " Nature Genetics, vol. 45, no. 11, pp. 1268-1269, 2013.
64. K. Arab, Y. J. Park, A. M. Lindroth et al., "Long noncoding RNA TARID directs demethylation and activation of the tumor suppressor TCF21 via GADD45A, " Molecular Cell, vol. 55, no. 4, pp. 604-614, 2014.
65. P. Monnier, C. Martinet, J. Pontis, I. Stancheva, S. Ait-Si-Ali, and L. Dandolo, "H19 lncRNA controls gene expression of the imprinted gene network by recruiting MBD1, " Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 51, pp. 20693-20698, 2013.
66. J. R. Prensner, M. K. Iyer, A. Sahu et al., "The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex, " Nature Genetics, vol. 45, no. 11, pp. 1392-1398, 2013.
67. Y. Tang, J. Wang, Y. Lian et al., "Linking long non-coding RNAs and SWI/SNF complexes to chromatin remodeling in cancer, " Molecular Cancer, vol. 16, no. 1, p. 42, 2017.
68. F. Yang, X. Deng, W. Ma et al., "The lncRNA Firre anchors the inactive X chromosome to the nucleolus by binding CTCF and maintains H3K27me3 methylation, " Genome Biology, vol. 16, no. 1, p. 52, 2015.
69. K. C. Wang, Y. W. Yang, B. Liu et al., "A long noncoding RNAmaintains active chromatin to coordinate homeotic gene expression, " Nature, vol. 472, no. 7341, pp. 120-124, 2011.
70. F. Lai, U. A. Orom, M. Cesaroni et al., "Activating RNAs associate with mediator to enhance chromatin architecture and transcription, " Nature, vol. 494, no. 7438, pp. 497-501, 2013.
71. J. F. Xiang, Q. F. Yin, T. Chen et al., "Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus, " Cell Research, vol. 24, no. 5, pp. 513-531, 2014.
72. J. C. Akers, D. Gonda, R. Kim, B. S. Carter, and C. C. Chen, "Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies, " Journal of Neuro-Oncology, vol. 113, no. 1, pp. 1-11, 2013.
73. D. A. Sartori and D. W. Chan, "Biomarkers in prostate cancer: what's new" Current Opinion in Oncology, vol. 26, no. 3, pp. 259-264, 2014.
74. H. Tang, Z. Wu, J. Zhang, and B. Su, "Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis, " Molecular Medicine Reports, vol. 7, no. 3, pp. 761-766, 2013.
75. E. M. Reis and S. Verjovski-Almeida, "Perspectives of long non-coding RNAs in cancer diagnostics, " Frontiers in Genetics, vol. 3, no. 32, p. 32, 2012.
76. Y. Shao, M. Ye, X. Jiang et al., "Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer, " Cancer, vol. 120, no. 21, pp. 3320-3328, 2014.
77. A. Silva, M. Bullock, and G. Calin, "The clinical relevance of long non-coding RNAs in cancer, " Cancer, vol. 7, no. 4, pp. 2169-2182, 2015.
78. P. Ji, S. Diederichs, W. Wang et al., "MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer, " Oncogene, vol. 22, no. 39, pp. 8031-8041, 2003.
79. Y. Fradet, F. Saad, A. Aprikian et al., "uPM3, a new molecular urine test for the detection of prostate cancer, " Urology, vol. 64, no. 2, pp. 311-315, 2004, discussion 315-316.
80. M. Tinzl, M. Marberger, S. Horvath, and C. Chypre, "DD3PCA3 RNA analysis in urine-a new perspective for detecting prostate cancer, " European Urology, vol. 46, no. 2, pp. 182-186, 2004, discussion 187.
81. S. B. Shappell, "Clinical utility of prostate carcinoma molecular diagnostic tests, " Reviews in Urology, vol. 10, no. 1, pp. 44-69, 2008.
82. M. Rasool, A. Malik, S. Zahid et al., "Non-coding RNAs in cancer diagnosis and therapy, " Non-coding RNA Research, vol. 1, no. 1, pp. 69-76, 2016.
83. X. Zhou, C. Yin, Y. Dang, F. Ye, and G. Zhang, "Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer, " Scientific Reports, vol. 5, article 11516, 2015.
84. S. Ren, F. Wang, J. Shen et al., "Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer, " European Journal of Cancer (Oxford, England: 1990), vol. 49, no. 13, pp. 2949-2959, 2013.
85. B. Hu, H. Yang, and H. Yang, "Diagnostic value of urine prostate cancer antigen 3 test using a cutoff value of 35 mug/L in patients with prostate cancer, " Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 35, no. 9, pp. 8573-8580, 2014.
86. T. Arita, D. Ichikawa, H. Konishi et al., "Circulating long non-coding RNAs in plasma of patients with gastric cancer, " Anticancer Research, vol. 33, no. 8, pp. 3185-3193, 2013.
87. K. Trajkovic, C. Hsu, S. Chiantia et al., "Ceramide triggers budding of exosome vesicles into multivesicular endosomes, " Science (New York, N. Y.), vol. 319, no. 5867, pp. 1244-1247, 2008.
88. R. M. Johnstone, "Exosomes biological significance: a concise review, " Blood Cells, Molecules & Diseases, vol. 36, no. 2, pp. 315-321, 2006.
89. X. Huang, T. Yuan, M. Tschannen et al., "Characterization of human plasma-derived exosomal RNAs by deep sequencing, " BMC Genomics, vol. 14, no. 1, p. 319, 2013.
90. Q. Li, Y. Shao, X. Zhang et al., "Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer, " Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 36, no. 3, pp. 2007-2012, 2015.
91. J. D. Arroyo, J. R. Chevillet, E. M. Kroh et al., "Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 12, pp. 5003-5008, 2011.
92. K. Wang, S. Zhang, J. Weber, D. Baxter, and D. J. Galas, "Export of microRNAs and microRNA-protective protein by mammalian cells, " Nucleic Acids Research, vol. 38, no. 20, pp. 7248-7259, 2010.
93. P. Qi, X. Zhou, and X. Du, "Circulating long non-coding RNAs in cancer: current status and future perspectives, " Molecular Cancer, vol. 15, no. 1, p. 39, 2016.
94. J. L. Huang, L. Zheng, Y. W. Hu, and Q. Wang, "Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma, " Carcinogenesis, vol. 35, no. 3, pp. 507-514, 2014.
95. G. L. Lee, A. Dobi, and S. Srivastava, "Prostate cancer: diagnostic performance of the PCA3 urine test, " Nature Reviews. Urology, vol. 8, no. 3, pp. 123-124, 2011.
96. S. B. Shappell, J. Fulmer, D. Arguello, B. S. Wright, J. R. Oppenheimer, and M. J. Putzi, "PCA3 urine mRNA testing for prostate carcinoma: patterns of use by community urologists and assay performance in reference laboratory setting, " Urology, vol. 73, no. 2, pp. 363-368, 2009.
97. D. Hessels, J. M. Klein Gunnewiek, I. van Oort et al., "DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer, " European Urology, vol. 44, no. 1, pp. 8-15, 2003, discussion 15-16.
98. W. J. Xue, X. L. Ying, J. H. Jiang, and Y. H. Xu, "Prostate cancer antigen 3 as a biomarker in the urine for prostate cancer diagnosis: a meta-analysis, " Journal of Cancer Research and Therapeutics, vol. 10, Supplement, pp. C218-C221, 2014.
99. R. Merola, L. Tomao, A. Antenucci et al., "PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience, " Journal of Experimental & Clinical Cancer Research: CR, vol. 34, no. 1, p. 15, 2015.
100. K. K. Chevli, M. Duff, P. Walter et al., "Urinary PCA3 as a predictor of prostate cancer in a cohort of 3, 073 men undergoing initial prostate biopsy, " The Journal of Urology, vol. 191, no. 6, pp. 1743-1748, 2014.
101. M. Svoboda, J. Slyskova, M. Schneiderova et al., "HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients, " Carcinogenesis, vol. 35, no. 7, pp. 1510-1515, 2014.
102. K. Panzitt, M. M. Tschernatsch, C. Guelly et al., "Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA, " Gastroenterology, vol. 132, no. 1, pp. 330-342, 2007.
103. H. Xie, H. Ma, and D. Zhou, "Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma, " BioMed Research International, vol. 2013, Article ID 136106, 5 pages, 2013.
104. Y. Zhao, Q. Guo, J. Chen, J. Hu, S. Wang, and Y. Sun, "Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation, " Oncology Reports, vol. 31, no. 1, pp. 358-364, 2014.
105. F. Guo, F. Yu, J. Wang et al., "Expression of MALAT1 in the peripheral whole blood of patients with lung cancer, " Biomedical Reports, vol. 3, no. 3, pp. 309-312, 2015.
106. D. G. Weber, G. Johnen, S. Casjens et al., "Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer, " BMC Research Notes, vol. 6, no. 1, p. 518, 2013.
107. F. Wang, S. Ren, R. Chen et al., "Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer, " Oncotarget, vol. 5, no. 22, pp. 11091-11102, 2014.
108. Q. Pang, J. Ge, Y. Shao et al., "Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance, " Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 35, no. 6, pp. 5441-5447, 2014.
109. J. Tang, R. Jiang, L. Deng, X. Zhang, K. Wang, and B. Sun, "Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma, " Oncotarget, vol. 6, no. 6, pp. 4505-4515, 2015.
110. X. S. Wang, Z. Zhang, H. C. Wang et al., "Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma, " Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, vol. 12, no. 16, pp. 4851-4858, 2006.
111. A. R. Dallosso, A. L. Hancock, S. Malik et al., "Alternately spliced WT1 antisense transcripts interact with WT1 sense RNA and show epigenetic and splicing defects in cancer, " RNA (New York, N. Y.), vol. 13, no. 12, pp. 2287-2299, 2007.
112. Y. Yao, J. Ma, Y. Xue et al., "Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating MIR-152, " Cancer Letters, vol. 359, no. 1, pp. 75-86, 2015.
113. Y. Wang, Y. Wang, J. Li, Y. Zhang, H. Yin, and B. Han, "CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling, " Cancer Letters, vol. 367, no. 2, pp. 122-128, 2015.
114. J. Ma, P. Wang, Y. Yao et al., "Knockdown of long noncoding RNA MALAT1 increases the blood-tumor barrier permeability by up-regulating MIR-140, " Biochimica et Biophysica Acta, vol. 1859, no. 2, pp. 324-338, 2016.
115. M. H. Yang, Z. Y. Hu, C. Xu et al., "MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9, " Biochimica et Biophysica Acta, vol. 1852, no. 1, pp. 166-174, 2015.
116. N. Huang, Y. Chi, J. Xue et al., "Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer, " Oncotarget, vol. 7, no. 25, pp. 37957-37965, 2016.
117. P. Malakar, A. Shilo, A. Mogilevsky et al., "Long noncoding RNA MALAT1 promotes hepatocellular carcinoma development by SRSF1 upregulation and mTOR activation, " Cancer Research, vol. 77, no. 5, pp. 1155-1167, 2017.
118. K. Yamada, J. Kano, H. Tsunoda et al., "Phenotypic characterization of endometrial stromal sarcoma of the uterus, " Cancer Science, vol. 97, no. 2, pp. 106-112, 2006.
119. J. M. Silva, N. J. Boczek, M. W. Berres, X. Ma, and D. I. Smith, "LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation, " RNA Biology, vol. 8, no. 3, pp. 496-505, 2011.
120. H. Li, L. Zhu, L. Xu et al., "Long noncoding RNA linc00617 exhibits oncogenic activity in breast cancer, " Molecular Carcinogenesis, vol. 56, no. 1, pp. 3-17, 2017.
121. N. Xu, F. Chen, F. Wang et al., "Clinical significance of high expression of circulating serum lncRNA RP11-445H22. 4 in breast cancer patients: a Chinese population-based study, " Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 36, no. 10, pp. 7659-7665, 2015.
122. A. Iacoangeli, Y. Lin, E. J. Morley et al., "BC200 RNA in invasive and preinvasive breast cancer, " Carcinogenesis, vol. 25, no. 11, pp. 2125-2133, 2004.
123. M. Yang, X. Zhai, B. Xia, Y. Wang, and G. Lou, "Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNA, " Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 36, no. 10, pp. 7615-7622, 2015.
124. Y. S. Tong, X. W. Wang, X. L. Zhou et al., "Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma, " Molecular Cancer, vol. 14, no. 1, p. 3, 2015.
125. X. Ge, Y. Chen, X. Liao et al., "Overexpression of long noncoding RNA PCAT-1 is a novel biomarker of poor prognosis in patients with colorectal cancer, " Medical Oncology (Northwood, London, England), vol. 30, no. 2, p. 588, 2013.
126. J. R. Prensner, W. Chen, S. Han et al., "The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc, " Neoplasia (New York, N. Y.), vol. 16, no. 11, pp. 900-908, 2014.
127. W. Wang, X. He, Z. Zheng et al., "Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma, " Molecular Cancer, vol. 16, no. 1, p. 75, 2017.
128. X. H. Liu, Z. L. Liu, M. Sun, J. Liu, Z. X. Wang, and W. De, "The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer, " BMC Cancer, vol. 13, no. 1, p. 464, 2013.
129. M. Lee, H. J. Kim, S. W. Kim et al., "The long non-coding RNA HOTAIR increases tumour growth and invasion in cervical cancer by targeting the Notch pathway, " Oncotarget, vol. 7, no. 28, pp. 44558-44571, 2016.
130. K. Kim, I. Jutooru, G. Chadalapaka et al., "HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer, " Oncogene, vol. 32, no. 13, pp. 1616-1625, 2013.
131. Y. Wu, L. Zhang, L. Zhang et al., "Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma, " International Journal of Oncology, vol. 46, no. 6, pp. 2586-2594, 2015.
132. Y. J. Geng, S. L. Xie, Q. Li, J. Ma, and G. Y. Wang, "Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression, " The Journal of International Medical Research, vol. 39, no. 6, pp. 2119-2128, 2011.
133. J. X. Zhang, L. Han, Z. S. Bao et al., "HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma, " Neuro-Oncology, vol. 15, no. 12, pp. 1595-1603, 2013.
134. J. Ke, Y. L. Yao, J. Zheng et al., "Knockdown of long noncoding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of MIR-326, " Oncotarget, vol. 6, no. 26, pp. 21934-21949, 2015.
135. M. Qiu, Y. Xu, X. Yang et al., "CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer, " Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 35, no. 6, pp. 5375-5380, 2014.
136. H. Ling, R. Spizzo, Y. Atlasi et al., "CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer, " Genome Research, vol. 23, no. 9, pp. 1446-1461, 2013.
137. L. Wu, L. Jin, W. Zhang, and L. Zhang, "Roles of long non-coding RNA CCAT2 in cervical cancer cell growth and apoptosis, " Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, vol. 22, pp. 875-879, 2016.
138. M. D. Xu, P. Qi, W. W. Weng et al., "Long non-coding RNA LSINCT5 predicts negative prognosis and exhibits oncogenic activity in gastric cancer, " Medicine, vol. 93, no. 28, article e303, 2014.
139. Q. Wang, J. Zhang, Y. Liu et al., "A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma, " Cancer Letters, vol. 373, no. 2, pp. 251-259, 2016.
140. H. Guo, L. Wu, Q. Yang, M. Ye, and X. Zhu, "Functional linc-POU3F3 is overexpressed and contributes to tumorigenesis in glioma, " Gene, vol. 554, no. 1, pp. 114-119, 2015.
141. C. C. Ma, Z. Xiong, G. N. Zhu et al., "Long non-coding RNA ATB promotes glioma malignancy by negatively regulating MIR-200a, " Journal of Experimental & Clinical Cancer Research: CR, vol. 35, no. 1, p. 90, 2016.
142. L. Hu, Q. L. Lv, S. H. Chen et al., "Up-regulation of long noncoding RNA AB073614 predicts a poor prognosis in patients with glioma, " International Journal of Environmental Research and Public Health, vol. 13, no. 4, p. 433, 2016.
143. T. Zhou and Y. Gao, "Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma, " World Journal of Surgical Oncology, vol. 14, no. 1, p. 8, 2015.
144. T. Zhang, C. Cao, D. Wu, and L. Liu, "SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma, " Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 37, no. 2, pp. 2379-2385, 2016.
145. Y. Shi, Q. Song, S. Yu, D. Hu, and X. Zhuang, "Microvascular invasion in hepatocellular carcinoma overexpression promotes cell proliferation and inhibits cell apoptosis of hepatocellular carcinoma via inhibiting MIR-199a expression, " OncoTargets and Therapy, vol. 8, pp. 2303-2310, 2015.
146. F. Q. Nie, Q. Zhu, T. P. Xu et al., "Long non-coding RNA MVIH indicates a poor prognosis for non-small cell lung cancer and promotes cell proliferation and invasion, " Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 35, no. 8, pp. 7587-7594, 2014.
147. N. M. White, C. R. Cabanski, J. M. Silva-Fisher, H. X. Dang, R. Govindan, and C. A. Maher, "Transcriptome sequencing reveals altered long intergenic non-coding RNAs in lung cancer, " Genome Biology, vol. 15, no. 8, p. 429, 2014.
148. M. Qiu, Y. Xu, J. Wang et al., "A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27, " Cell Death & Disease, vol. 6, no. 8, article e1858, 2015.
149. Z. Zeng, H. Bo, Z. Gong et al., "AFAP1-AS1, a long noncoding RNA upregulated in lung cancer and promotes invasion and metastasis, " Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 37, no. 1, pp. 729-737, 2016.
150. X. Han, L. Wang, Y. Ning, S. Li, and Z. Wang, "Long noncoding RNA AFAP1-AS1 facilitates tumor growth and promotes metastasis in colorectal cancer, " Biological Research, vol. 49, no. 1, p. 36, 2016.
151. X. Lu, C. Zhou, R. Li et al., "Critical role for the long noncoding RNA AFAP1-AS1 in the proliferation and metastasis of hepatocellular carcinoma, " Tumour Biology, vol. 37, no. 7, pp. 9699-9707, 2016.
152. H. L. Luo, M. D. Huang, J. N. Guo et al., "AFAP1-AS1 is upregulated and promotes esophageal squamous cell carcinoma cell proliferation and inhibits cell apoptosis, " Cancer Medicine, vol. 5, no. 10, pp. 2879-2885, 2016.
153. F. Q. Nie, M. Sun, J. S. Yang et al., "Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression, " Molecular Cancer Therapeutics, vol. 14, no. 1, pp. 268-277, 2015.
154. M. Huang, W. Chen, F. Qi et al., "Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell apoptosis by epigenetic silencing of KLF2, " Journal of Hematology & Oncology, vol. 8, no. 50, 2015.
155. H. Zhu, X. Li, Y. Song, P. Zhang, Y. Xiao, and Y. Xing, "Long non-coding RNA ANRIL is up-regulated in bladder cancer and regulates bladder cancer cell proliferation and apoptosis through the intrinsic pathway, " Biochemical and Biophysical Research Communications, vol. 467, no. 2, pp. 223-228, 2015.
156. W. Nie, H. J. Ge, X. Q. Yang et al., "LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting MIR-193a-3p, " Cancer Letters, vol. 371, no. 1, pp. 99-106, 2016.
157. Y. T. Yang, Y. F. Wang, J. Y. Lai et al., "Long non-coding RNA UCA1 contributes to the progression of oral squamous cell carcinoma by regulating the WNT/-catenin signaling pathway, " Cancer Science, vol. 107, no. 11, pp. 1581-1589, 2016.
158. A. K. Srivastava, P. K. Singh, S. K. Rath, D. Dalela, M. M. Goel, and M. L. Bhatt, "Appraisal of diagnostic ability of UCA1 as a biomarker of carcinoma of the urinary bladder, " Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 35, no. 11, pp. 11435-11442, 2014.
159. Y. Han, Y. N. Yang, H. H. Yuan et al., "UCA1, a long noncoding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution, " Pathology, vol. 46, no. 5, pp. 396-401, 2014.
160. J. N. Xiao, T. H. Yan, R. M. Yu et al., "Long non-coding RNA UCA1 regulates the expression of Snail2 by MIR-203 to promote hepatocellular carcinoma progression, " Journal of Cancer Research and Clinical Oncology, vol. 143, no. 6, pp. 981-990, 2017.
161. Y. L. Tuo, X. M. Li, and J. Luo, "Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive MIR-143, " European Review for Medical and Pharmacological Sciences, vol. 19, no. 18, pp. 3403-3411, 2015.
162. J. Y. Li, X. Ma, and C. B. Zhang, "Overexpression of long noncoding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma, " International Journal of Clinical and Experimental Pathology, vol. 7, no. 11, pp. 7938-7944, 2014.
163. L. Lessard, M. Liu, D. M. Marzese et al., "The CASC15 long intergenic noncoding RNA locus is involved in melanoma progression and phenotype switching, " The Journal of Investigative Dermatology, vol. 135, no. 10, pp. 2464-2474, 2015.
164. D. Khaitan, M. E. Dinger, J. Mazar et al., "The melanomaupregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion, " Cancer Research, vol. 71, no. 11, pp. 3852-3862, 2011.
165. J. Mazar, W. Zhao, A. M. Khalil et al., "The functional characterization of long noncoding RNA SPRY4-IT1 in human melanoma cells, " Oncotarget, vol. 5, no. 19, pp. 8959-8969, 2014.
166. H. Liu, Z. Lv, and E. Guo, "Knockdown of long noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation, metastasis and epithelial-mesenchymal transition, " International Journal of Clinical and Experimental Pathology, vol. 8, no. 8, pp. 9140-9146, 2015.
167. M. Luo, Z. Li, W. Wang, Y. Zeng, Z. Liu, and J. Qiu, "Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression, " Cancer Letters, vol. 333, no. 2, pp. 213-221, 2013.
168. D. Tan, Y. Wu, L. Hu et al., "Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis, " Diseases of the Esophagus: Official Journal of the International Society for Diseases of the Esophagus, vol. 30, no. 1, pp. 1-9, 2017.
169. W. Yang, N. Ning, and X. Jin, "The lncRNA H19 promotes cell proliferation by competitively binding to MIR-200a and derepressing beta-catenin expression in colorectal cancer, " BioMed Research International, vol. 2017, Article ID 2767484, 8 pages, 2017.
170. Y. Shi, Y. Wang, W. Luan et al., "Long non-coding RNA H19 promotes glioma cell invasion by deriving MIR-675, " PloS One, vol. 9, no. 1, article e86295, 2014.
171. W. Peng, W. Gao, and J. Feng, "Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer, " Medical Oncology (Northwood, London, England), vol. 31, no. 12, p. 346, 2014.
172. Y. Zhu, X. Zhang, L. Qi et al., "HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas, " Oncotarget, vol. 7, no. 12, pp. 14429-14440, 2016.
173. A. Ylipaa, K. Kivinummi, A. Kohvakka et al., "Transcriptome sequencing reveals PCAT5 as a novel ERG-regulated long noncoding RNA in prostate cancer, " Cancer Research, vol. 75, no. 19, pp. 4026-4031, 2015.
174. F. Crea, A. Watahiki, L. Quagliata et al., "Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer, " Oncotarget, vol. 5, no. 3, pp. 764-774, 2014.
175. S. Chung, H. Nakagawa, M. Uemura et al., "Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility, " Cancer Science, vol. 102, no. 1, pp. 245-252, 2011.
176. C. He, B. Jiang, J. Ma, and Q. Li, "Aberrant NEAT1 expression is associated with clinical outcome in high grade glioma patients, " APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica, vol. 124, no. 3, pp. 169-174, 2016.
177. L. Zhen, L. Yun-Hui, D. Hong-Yu, M. Jun, and Y. Yi-Long, "Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating MIR-449b-5p/c-Met axis, " Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 37, no. 1, pp. 673-683, 2016.
178. S. Guo, W. Chen, Y. Luo et al., "Clinical implication of long non-coding RNA NEAT1 expression in hepatocellular carcinoma patients, " International Journal of Clinical and Experimental Pathology, vol. 8, no. 5, pp. 5395-5402, 2015.
179. Y. Lu, T. Li, G. Wei et al., "The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through MIR-204/ZEB1 axis in nasopharyngeal carcinoma, " Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 37, no. 9, pp. 11733-11741, 2016.
180. Q. Zhou, J. Chen, J. Feng, and J. Wang, "Long noncoding RNA PVT1 modulates thyroid cancer cell proliferation by recruiting EZH2 and regulating thyroid-stimulating hormone receptor (TSHR), " Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 37, no. 3, pp. 3105-3113, 2016.
181. R. Kong, E. B. Zhang, D. D. Yin et al., "Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16, " Molecular Cancer, vol. 14, no. 1, p. 82, 2015.
182. Y. Takahashi, G. Sawada, J. Kurashige et al., "Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers, " British Journal of Cancer, vol. 110, no. 1, pp. 164-171, 2014.
183. R. Yan, K. Wang, R. Peng et al., "Genetic variants in lncRNA SRA and risk of breast cancer, " Oncotarget, vol. 7, no. 16, pp. 22486-22496, 2016.
184. P. Wang, Z. Ren, and P. Sun, "Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation, " Journal of Cellular Biochemistry, vol. 113, no. 6, pp. 1868-1874, 2012.
185. J. Li, E. B. Bian, X. J. He et al., "Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas, " International Journal of Oncology, vol. 48, no. 2, pp. 723-733, 2016.
186. M. E. Askarian-Amiri, J. Crawford, J. D. French et al., "SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer, " RNA (New York, N. Y.), vol. 17, no. 5, pp. 878-891, 2011.
187. M. Mourtada-Maarabouni, M. R. Pickard, V. L. Hedge, F. Farzaneh, and G. T. Williams, "GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer, " Oncogene, vol. 28, no. 2, pp. 195-208, 2009.
188. X. Zhao, P. Wang, J. Liu et al., "Gas5 exerts tumorsuppressive functions in human glioma cells by targeting MIR-222, " Molecular Therapy: The Journal of the American Society of Gene Therapy, vol. 23, no. 12, pp. 1899-1911, 2015.
189. J. Ding, B. Lu, J. Wang et al., "Long non-coding RNA Loc554202 induces apoptosis in colorectal cancer cells via the caspase cleavage cascades, " Journal of Experimental & Clinical Cancer Research: CR, vol. 34, no. 1, article 100, 2015.
190. L. Dong, P. Qi, M. D. Xu et al., "Circulating CUDR, LSINCT-5 and PTENP1 long noncoding RNAs in sera distinguish patients with gastric cancer from healthy controls, " International Journal of Cancer, vol. 137, no. 5, pp. 1128-1135, 2015.
191. L. Poliseno, L. Salmena, J. Zhang, B. Carver, W. J. Haveman, and P. P. Pandolfi, "A coding-independent function of gene and pseudogene mRNAs regulates tumour biology, " Nature, vol. 465, no. 7301, pp. 1033-1038, 2010.
192. Z. H. Fei, X. J. Yu, M. Zhou, H. F. Su, Z. Zheng, and C. Y. Xie, "Upregulated expression of long non-coding RNA LINC00982 regulates cell proliferation and its clinical relevance in patients with gastric cancer, " Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 37, no. 2, pp. 1983-1993, 2016.
193. X. Qin, J. Yao, P. Geng, X. Fu, J. Xue, and Z. Zhang, "LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma, " International Journal of Clinical and Experimental Pathology, vol. 7, no. 6, pp. 3065-3072, 2014.
194. J. Yao, B. Zhou, J. Zhang et al., "A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells, " Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 35, no. 8, pp. 7935-7944, 2014.
195. H. Yue, J. Zhu, S. Xie, F. Li, and Q. Xu, "MDC1-AS, an antisense long noncoding RNA, regulates cell proliferation of glioma, " Biomedicine & Pharmacotherapy, vol. 81, pp. 203-209, 2016.
196. J. Li, M. Zhang, G. An, and Q. Ma, "LncRNA TUG1 acts as a tumor suppressor in human glioma by promoting cell apoptosis, " Experimental Biology and Medicine (Maywood, N. J.), vol. 241, no. 6, pp. 644-649, 2016.
197. S. Feng, J. Yao, Y. Chen et al., "Expression and functional role of reprogramming-related long noncoding RNA (lincRNAROR) in glioma, " Journal of Molecular Neuroscience: MN, vol. 56, no. 3, pp. 623-630, 2015.
198. P. Wang, Y. H. Liu, Y. L. Yao et al., "Long non-coding RNA CASC2 suppresses malignancy in human gliomas by MIR-21, " Cellular Signalling, vol. 27, no. 2, pp. 275-282, 2015.
199. C. C. Zhou, F. Yang, S. X. Yuan et al., "Systemic genome screening identifies the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinoma, " Hepatology (Baltimore, Md.), vol. 63, no. 3, pp. 850-863, 2016.
200. H. He, R. Nagy, S. Liyanarachchi et al., "A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24, " Cancer Research, vol. 69, no. 2, pp. 625-631, 2009.
201. J. H. Yang, J. H. Li, S. Jiang, H. Zhou, and L. H. Qu, "ChIPBase: a database for decoding the transcriptional regulation of long non-coding RNA and microRNA genes from ChIPSeq data, " Nucleic Acids Research, vol. 41, no. Database issue, pp. D177-D187, 2013.
202. T. Weirick, D. John, S. Dimmeler, and S. Uchida, "C-It-Loci: a knowledge database for tissue-enriched loci, " Bioinformatics (Oxford, England), vol. 31, no. 21, pp. 3537-3543, 2015.
203. Z. Zhao, J. Bai, A. Wu et al., "Co-LncRNA: investigating the lncRNA combinatorial effects in GO annotations and KEGG pathways based on human RNA-Seq data, " Database: The Journal of Biological Databases and Curation, vol. 2015, article bav082, 2015.
204. M. D. Paraskevopoulou, G. Georgakilas, N. Kostoulas et al., "DIANA-LncBase: experimentally verified and computationally predicted microRNA targets on long non-coding RNAs, " Nucleic Acids Research, vol. 41, Database issue, pp. D239-D245, 2013.
205. M. D. Paraskevopoulou, I. S. Vlachos, D. Karagkouni et al., "DIANA-LncBase v2: indexing microRNA targets on noncoding transcripts, " Nucleic Acids Research, vol. 44, no. D1, pp. D231-D238, 2016.
206. K. Liu, Z. Yan, Y. Li, and Z. Sun, "Linc2GO: a human LincRNA function annotation resource based on ceRNA hypothesis, " Bioinformatics (Oxford, England), vol. 29, no. 17, pp. 2221-2222, 2013.
207. S. Ning, J. Zhang, P. Wang et al., "Lnc2Cancer: a manually curated database of experimentally supported lncRNAs associated with various human cancers, " Nucleic Acids Research, vol. 44, no. D1, pp. D980-D985, 2016.
208. P. Wang, S. Ning, Y. Zhang et al., "Identification of lncRNAassociated competing triplets reveals global patterns and prognostic markers for cancer, " Nucleic Acids Research, vol. 43, no. 7, pp. 3478-3489, 2015.
209. P. J. Volders, K. Helsens, X. Wang et al., "LNCipedia: a database for annotated human lncRNA transcript sequences and structures, " Nucleic Acids Research, vol. 41, Database issue, pp. D246-D251, 2013.
210. P. J. Volders, K. Verheggen, G. Menschaert et al., "An update on LNCipedia: a database for annotated human lncRNA sequences, " Nucleic Acids Research, vol. 43, no. 8, pp. 4363-4364, 2015.
211. S. Chakraborty, A. Deb, R. K. Maji, S. Saha, and Z. Ghosh, "LncRBase: an enriched resource for lncRNA information, " PloS One, vol. 9, no. 9, article e108010, 2014.
212. Q. Jiang, R. Ma, J. Wang et al., "LncRNA2Function: a comprehensive resource for functional investigation of human lncRNAs based on RNA-seq data, " BMC Genomics, vol. 16, Supplement 3, p. S2, 2015.
213. P. P. Amaral, M. B. Clark, D. K. Gascoigne, M. E. Dinger, and J. S. Mattick, "lncRNAdb: a reference database for long noncoding RNAs, " Nucleic Acids Research, vol. 39, Database issue, pp. D146-D151, 2011.
214. X. C. Quek, D. W. Thomson, J. L. Maag et al., "lncRNAdb v2. 0: expanding the reference database for functional long noncoding RNAs, " Nucleic Acids Research, vol. 43, Database issue, pp. D168-D173, 2015.
215. G. Chen, Z. Wang, D. Wang et al., "LncRNADisease: a database for long-non-coding RNA-associated diseases, " Nucleic Acids Research, vol. 41, Database issue, pp. D983-D986, 2013.
216. J. Gong, W. Liu, J. Zhang, X. Miao, and A. Y. Guo, "lncRNASNP: a database of SNPs in lncRNAs and their potential functions in human and mouse, " Nucleic Acids Research, vol. 43, Database issue, pp. D181-D186, 2015.
217. D. Bhartiya, K. Pal, S. Ghosh et al., "lncRNome: a comprehensive knowledgebase of human long noncoding RNAs, " Database: The Journal of Biological Databases and Curation, vol. 2013, p. bat034, 2013.
218. A. Jeggari, D. S. Marks, and E. Larsson, "miRcode: a map of putative microRNA target sites in the long non-coding transcriptome, " Bioinformatics (Oxford, England), vol. 28, no. 15, pp. 2062-2063, 2012.
219. C. Liu, B. Bai, G. Skogerbo et al., "NONCODE: an integrated knowledge database of non-coding RNAs, " Nucleic Acids Research, vol. 33, Database issue, pp. D112-D115, 2005.
220. Y. Zhao, H. Li, S. Fang et al., "NONCODE 2016: an informative and valuable data source of long non-coding RNAs, " Nucleic Acids Research, vol. 44, no. D1, pp. D203-D208, 2016.
221. J. H. Yang, J. H. Li, P. Shao, H. Zhou, Y. Q. Chen, and L. H. Qu, "starBase: a database for exploring microRNAmRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data, " Nucleic Acids Research, vol. 39, Database issue, pp. D202-D209, 2011.
222. J. H. Li, S. Liu, H. Zhou, L. H. Qu, and J. H. Yang, "starBase v2. 0: decoding MIRNA-ceRNA, MIRNA-ncRNA and protein-RNA interaction networks from large-scale CLIPSeq data, " Nucleic Acids Research, vol. 42, Database issue, pp. D92-D97, 2014.